Duncan McKechnie, EVP, Chief Commercial Officer: Vertex Pharmaceuticals VRTX Sell · Filed 02/26

Trade details

Type: Insider sale
Amount: $1,215,875
Shares · price: 2,500 sh · $486.35 a share
Held after: 19,969 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Duncan McKechnieEVP, Chief Commercial Officer
Trade date: 26/02/25
Filed: 26/02/26
Days to filing: 1 days

Sold 11.1% of holdings

Share of holding sold: 11.1%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/26~03/27

Duncan McKechnie's recent trades

Duncan McKechnieEVP, Chief Commercial Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$799.8K
1,541 sh
$799.8K
Filed 07/02
Traded 07/02
Duncan McKechnieEVP, Chief Commercial Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.3M
2,633 sh
$1.3M
Filed 03/13
Traded 03/11
Duncan McKechnieEVP, Chief Commercial Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.3M
2,633 sh
$1.3M
Filed 03/11
Traded 03/11
Duncan McKechnieEVP, Chief Commercial Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,437 sh
$1.2M
Filed 03/06
Traded 03/04
Duncan McKechnieEVP, Chief Commercial Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,437 sh
$1.2M
Filed 03/04
Traded 03/04